Is the removal of a central venous catheter always necessary in the context of catheter-related right atrial thrombosis?
Adult
Anticoagulants
/ administration & dosage
Catheterization, Central Venous
/ adverse effects
Catheters, Indwelling
/ adverse effects
Central Venous Catheters
/ adverse effects
Clinical Decision-Making
Device Removal
Echocardiography
Fibrinolytic Agents
/ administration & dosage
Heart Diseases
/ diagnostic imaging
Humans
Kidney Failure, Chronic
/ diagnosis
Male
Renal Dialysis
Thrombolytic Therapy
/ methods
Thrombosis
/ diagnostic imaging
Tomography, X-Ray Computed
Treatment Outcome
Urokinase-Type Plasminogen Activator
/ administration & dosage
Catheter-related right atrial thrombosis
anticoagulation therapy
catheter removal
thrombolytic therapy
Journal
The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
12
5
2018
medline:
10
4
2019
entrez:
12
5
2018
Statut:
ppublish
Résumé
Catheter-related right atrial thrombosis is a severe and life-threatening complication of central venous catheters in both adult and young patients. Catheter-related right atrial thrombosis can occur with any type of central venous catheters, utilized either for hemodialysis or infusion. Up to 30% of patients with central venous catheter are estimated to be affected by catheter-related right atrial thrombosis; however, neither precise epidemiological data nor guidelines regarding medical or surgical treatment are available. This complication seems to be closely associated with positioning of the catheter tip in the atrium, whereas it is unlikely with a tip located within superior vena cava. Herein, we report the case of a patient affected by catheter-related right atrial thrombosis, who showed a quick resolution of thrombosis with a new therapeutic scheme combining loco-regional thrombolytic therapy (urokinase as a locking solution) and systemic anticoagulation therapy (vitamin K antagonists), thus avoiding catheter removal. Neither complications of the combination therapy were reported, nor recurrence of catheter-related right atrial thrombosis occurred. In conclusion, the combination therapy here described was safe, quick and effective, achieving the goal of not removing the catheter.
Identifiants
pubmed: 29749281
doi: 10.1177/1129729818774438
doi:
Substances chimiques
Anticoagulants
0
Fibrinolytic Agents
0
Urokinase-Type Plasminogen Activator
EC 3.4.21.73
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM